MYGN FY 2016 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$454M

FY 2016 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$771M+2.3% YoY

Gross Profit

$600M77.8% margin

Operating Income

$49M6.4% margin

Net Income

$22M2.8% margin

EPS (Diluted)

$0.32

Cash Flow

Operating Cash Flow

$106M

Free Cash Flow

$100M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$447M

Stockholders' Equity

$778M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$771M	$754M	+2.3%
Gross Profit	$600M	$597M	+0.6%
Operating Income	$49M	$167M	-70.4%
Net Income	$22M	$125M	-82.6%